Fuse Medical, Inc.
FZMD
$0.0999
$0.037961.13%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 195.26% | 52.06% | 1,110.82% | 98.65% | -277.66% |
| Total Depreciation and Amortization | -4.94% | -2.91% | -524.88% | 466.90% | 121.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 252.14% | -32.22% | -356.95% | 135.07% | 34.92% |
| Change in Net Operating Assets | -440.46% | -51.70% | -35.54% | -92.45% | -53.15% |
| Cash from Operations | 59.71% | -33.01% | 58.63% | 214.65% | -315.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -56.79% | 48.97% | 97.11% | -5,308.11% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.79% | 48.97% | -105.95% | -156.48% | 287.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.98% | 305.54% | 70.46% | -124.00% | 233.83% |